; we focused on the first two cohorts of entrants (entry in 2012 or 2013) to allow for at least two years of post-entry data, then compared ACO-entrants with those who had yet to join. The ACO also identified high-risk beneficiaries and enrolled them in an integrated Care Management Program (iCMP), which provided additional routes through which to receive care, beyond that available from their primary care physicians. Because of program capacity constraints, iCMP program entry was staggered. For both the ACO-entrants and iCMP entrants, we examined the pre-program trends in ED use for those who started earlier versus later, and found the trends to be comparable. We then examined changes in visit rates over time (within-person) for earlier versus later entrants, using Poisson or logistic regression models with individual-level fixed effects, and adjusted for changes in risk scores (i.e., CMS-HCC scores), calendar month, and year. We examined ED visit rates overall, and then for conditions treatable with timely outpatient care. For the latter, we classified the ED visits using the NYU algorithm, i.e., using a 50% probability threshold that an ED visit was for conditions likely to be nonemergent or primary care treatable. We also conducted sensitivity analyses with different probability thresholds.
States
Objectives: Changes in care delivery patterns represent one mechanism for reducing medical spending growth while preserving or improving quality. For example, many visits to the Emergency Department (ED) are for conditions that could be addressed in lower-cost outpatient clinics, or could be avoided altogether with better outpatient access. Using 2009-14 Medicare claims for a large Pioneer Accountable Care Organization (ACO), we examined whether ACO entry or intensive care management receipt was associated with Medicare beneficiary ED visit rates. Methods: Beneficiaries could join the ACO between 2012-14 (Pioneer contract years); we focused on the first two cohorts of entrants (entry in 2012 or 2013) to allow for at least two years of post-entry data, then compared ACO-entrants with those who had yet to join. The ACO also identified high-risk beneficiaries and enrolled them in an integrated Care Management Program (iCMP), which provided additional routes through which to receive care, beyond that available from their primary care physicians. Because of program capacity constraints, iCMP program entry was staggered. For both the ACO-entrants and iCMP entrants, we examined the pre-program trends in ED use for those who started earlier versus later, and found the trends to be comparable. We then examined changes in visit rates over time (within-person) for earlier versus later entrants, using Poisson or logistic regression models with individual-level fixed effects, and adjusted for changes in risk scores (i.e., CMS-HCC scores), calendar month, and year. We examined ED visit rates overall, and then for conditions treatable with timely outpatient care. For the latter, we classified the ED visits using the NYU algorithm, i.e., using a 50% probability threshold that an ED visit was for conditions likely to be nonemergent or primary care treatable. We also conducted sensitivity analyses with different probability thresholds. Results: There were 42,050 beneficiaries who entered the ACO in 2012, and 19,521 in 2013. Within the 2012 cohort, the ACO classified 11.2% beneficiaries as eligible for the high-risk iCMP program; of these, 65% started the program during the study period. Within the 2013 cohort, the ACO classified 11.7% beneficiaries as iCMP eligible; of these, 39.0% started during the study period. In adjusted models, ACO entry was associated with a 3.6% decreases in ED visit rates (95% CI: 1.5% to 5.6% decrease). ACO entry also was associated with lower odds of ED visits for outpatient treatable conditions (OR = 0.905; 95%CI: 0.872-0.941). Among the higher risk beneficiaries who were eligible for the iCMP program, starting the program was associated with an 8.0% decrease in ED visit rates (95% CI: 4.7-11.1% decrease). Program entry also was associated with lower odds of visits for outpatient treatable conditions (OR = 0.918; 95%CI: 0.857-0.982). Analyses altering the ED classification threshold yielded comparable findings. Conclusion: Entry into a Medicare Pioneer ACO is associated with decreases in ED visit rates for all visits and visits for conditions treatable in outpatient clinics. Among the ACO population, entry into a high-risk care management program had similar additional effects. Alternative payment models such as those for Pioneer ACOs (e.g., shared upside and downside risk) could alter care delivery patterns, and thereby have the potential to slow medical spending growth. 
